US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh

The U.S. Food and Drug Administration (FDA) conducted an inspection at Aurobindo Pharma Limited, Unit XIV, FEI 3014477031, located at Plot No 17, E-Bonangi Village, Jawaharlal Nehru Pharma City, Parawada Mandal, Anakapalli District, Andhra Pradesh, from 15th May to 19th May 2023. The Unit has now received Establishment Inspection Report classifying the facility as "Voluntary action indicated" ("VAI").

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 738.90 as compared to the previous close of Rs. 724.45. The total number of shares traded during the day was 51337 in over 2261 trades.

The stock hit an intraday high of Rs. 742.90 and intraday low of 723.40. The net turnover during the day was Rs. 37838200.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 USFDA EIR VAI UnitXIV Inspection